BFA
BRLI

BlackRock Fund Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BlackRock Fund Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,576,481
Closed -$65M – 3934
2015
Q2 		$65M Buy
1,576,481
+21,760
+1% +$780K 0.02% 1344
2015
Q1 		$54.8M Buy
1,554,721
+103,070
+7% +$3.49M 0.01% 1448
2014
Q4 		$46.6M Buy
1,451,651
+115,880
+9% +$3.35M 0.01% 1514
2014
Q3 		$37.5M Sell
1,335,771
-6,116
-0.5% -$186K 0.01% 1549
2014
Q2 		$40.6M Sell
1,341,887
-69,779
-5% -$1.93M 0.01% 1539
2014
Q1 		$39.1M Buy
1,411,666
+19,593
+1% +$513K 0.01% 1573
2013
Q4 		$35.6M Buy
1,392,073
+25,305
+2% +$780K 0.01% 1627
2013
Q3 		$40.8M Buy
1,366,768
+159,100
+13% +$4.42M 0.01% 1483
2013
Q2 		$34.7M Buy
+1,207,668
New +$33.3M 0.01% 1467

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BlackRock Fund Advisors's BRLI Position: Q3 2015 in Review

BlackRock Fund Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,576,481 shares — an estimated $65M sold.

BlackRock Fund Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $65M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • BlackRock Fund Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,576,481 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $65M.
  • BlackRock Fund Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • BlackRock Fund Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $65M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BlackRock Fund Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.